Skip to main content
Jacob Glass, MD, Oncology, New York, NY

JacobGlassMD

Oncology New York, NY

Physician

Dr. Glass is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Glass' full profile

Already have an account?

  • Office

    505 E 70th St
    Weill Cornell Internal Medicine Associates, Box 148
    New York, NY 10021
    Phone+1 212-746-3587
    Fax+1 212-746-4609

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2012 - 2016
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2010 - 2012
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 2010

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2018 - 2025
  • NY State Medical License
    NY State Medical License 2012 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology
  • American Board of Preventive Medicine Clinical Informatics

Publications & Presentations

PubMed

Abstracts/Posters

  • Leukemia Cell of Origin Influences p53 Activity and Therapeutic Sensitivity Via an Evi1-Dependent Mechanism
    Jacob L Glass, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • RAS Mutations Are Independently Associated with Decreased Overall Survival and Event-Free Survival in Patients with AML Receiving Induction Chemotherapy
    Jacob L Glass, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Acute Leukemia with Lineage Infidelity: Mixed Phenotype AML Exhibits a Distinct Immunophenotype with Clinical Features Overlapping Mixed Phenotype Acute Leukemia
    Jacob L Glass, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • AML with Mutations in IDH1 and DNMT3A Exhibits a Distinct Epigenetic Signature with Poorer Overall Survival 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Loss of Plasmacytoid Dendritic Cell Differentiation Is Highly Predictive for Persistent Measurable Residual Disease and Poor Outcomes in Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018